ALKYLATING AGENTS IN CLINICAL CANCER CHEMOTHERAPY*
- 1 October 1969
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 163 (2), 921-930
- https://doi.org/10.1111/j.1749-6632.1969.tb24911.x
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- STRUCTURE-ACTIVITY RELATIONSHIPS OF ALKYLATING AGENTS IN CANCER CHEMOTHERAPYAnnals of the New York Academy of Sciences, 1969
- Clinical Pharmacology of the Effective Antitumor DrugsAnnual Review of Pharmacology, 1965
- Cytotoxic Activity Compared with Photometric Measurements of Selected Alkylating AgentsNature, 1965
- The initial clinical trial of nitrogen mustardThe American Journal of Surgery, 1963
- Some interactions of nitrogen mustards with constituents of human blood serumBiochemical Pharmacology, 1961
- Comparison of chlorambucil and Myleran® in chronic lymphocytic and granulocytic leukemiaThe American Journal of Medicine, 1959
- THE EFFECT OF L-CYSTEINE ON NITROGEN MUSTARD THERAPYThe Lancet Healthy Longevity, 1952
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948
- The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and SulfidesScience, 1946
- EXPERIMENTAL AND CLINICAL STUDIES ON THE TREATMENT OF CANCER BY DICHLORETHYLSULPHIDE (MUSTARD GAS)Annals of Surgery, 1931